Immix BiopharmaIMMX
13F holders, Q1 2024 (March 31)35holders
2famous investors
$3.09avg. 13F price*
At the end of Q1 2024, 35 institutions reported holding Immix Biopharma Inc. (IMMX) in their 13F filings. The largest holders were AIGH Capital Management LLC ($4.8M), Bleichroeder LP ($2.6M) and Cable Car Capital, LP ($2.1M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Immix Biopharma Inc.
- CUSIP
- 45258H106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 14 | $11.6M |
| Exits | 7 | $1.2M |
Ownership 35 holders
| AIGH Capital Management LLC | 2.30% | New | 1,555,000 | $4.8M |
| Bleichroeder LP | 0.65% | New | 850,000 | $2.6M |
| Cable Car Capital, LP | 3.05% | New | 670,458 | $2.1M |
| Vanguard Group Inc. | 0.00% | Add +184.4% | 456,186 | $1.4M |
| Lynwood Capital Management Inc. | 7.47% | New | 405,000 | $1.2M |
| Renaissance Technologies | 0.00% | Add +719.4% | 265,500 | $815K |
| Geode Capital Management, LLC | 0.00% | Add +49.6% | 124,770 | $383K |
| Private Advisor Group, LLC | 0.00% | Reduce -1.0% | 98,775 | $303K |
| Susquehanna International Group, LLP | 0.00% | Add +435.9% | 76,901 | $236K |
| Corsair Capital Management, L.P. | 0.06% | New | 69,385 | $213K |
| Tritonpoint Wealth, LLC | 0.02% | New | 24,526 | $170K |
| Millennium Management | 0.00% | New | 54,281 | $167K |
| Morgan Stanley | 0.00% | Add +234.3% | 54,045 | $166K |
| XTX Topco Ltd | 0.02% | New | 52,197 | $160K |
| State Street Corp. | 0.00% | No change | 42,960 | $132K |
| Northern Trust Corp. | 0.00% | Add +59.6% | 38,914 | $119K |
| Tocqueville Asset Management L.P. | 0.00% | Add +89.0% | 37,800 | $116K |
| Commonwealth Equity Services, LLC | 0.00% | Reduce -7.8% | 26,080 | $80K |
| FNY Investment Advisers, LLC | 0.05% | New | 25,500 | $78K |
| Imprint Wealth LLC | 0.02% | Reduce -24.0% | 26,214 | $77K |
| Dimensional Fund Advisors LP | 0.00% | Add +105.9% | 24,528 | $75K |
| Two Sigma Investments, LP | 0.00% | New | 22,862 | $70K |
| Walleye Capital LLC | 0.00% | New | 21,926 | $67K |
| BlackRock Inc. | 0.00% | Add +9.1% | 19,321 | $59K |
| InterOcean Capital Group, LLC | 0.00% | No change | 11,900 | $37K |
| Old National Bancorp | 0.00% | No change | 10,000 | $31K |
| JPMorgan Chase & Co. | 0.00% | Add +1233.2% | 9,039 | $28K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +887.2% | 5,696 | $17K |
| UBS Group AG | 0.00% | Add +100.1% | 5,258 | $16K |
| Steward Partners Investment Advisory, LLC | 0.00% | New | 1,492 | $5K |
| Tortoise Investment Management, LLC | 0.00% | No change | 1,300 | $4K |
| Qube Research & Technologies Ltd | 0.00% | New | 1,243 | $4K |
| Wells Fargo & Company | 0.00% | Add +11.0% | 434 | $1K |
| Simplex Trading, LLC | 0.00% | New | 509 | $1K |
| Royal Bank of Canada | 0.00% | Reduce -91.2% | 6 | $0 |
"% of holder's portfolio" is IMMX's weight in each manager's 13F, not the share of Immix Biopharma Inc. the manager owns.